19,000 per cent returns in this multibagger stock: Board announces stock split; stock trades at high ROE & high ROCE!

The stock has delivered mind-boggling returns for investors, generating multibagger returns of 2,120 per cent in just 1 year.

Remedium Lifecare Ltd informed that The Board of Directors of the company has approved and recommended for sub-division of the company's 1 (one) equity share of face value of Rs 5 each into 5 (five) equity shares of face value of Rs 1 each held as on the Record date which shall be decided for this purpose. The expected time of completion of the stock split is approximately within 3 months.

Today, shares of Remedium Lifecare Ltd plunged 2.50 per cent to Rs 557.45 per share with an intraday high of Rs 572.90 and an intraday low of Rs 520. The stock’s 52-week high is Rs 893.30 and its 52-week low is Rs 24.68.

Remedium Lifecare Ltd is in the business of trading in advanced pharmaceutical intermediates and other pharma products. The company has a market cap of Rs 1,124 crore with a 3-year stock price CAGR of 200 per cent.

According to the Quarterly Results, the net sales increased by 195.7 per cent to Rs 468.57 crore and net profit increased by 198.2 per cent to Rs 6.53 crore in Q2FY24 compared to Q2FY23. In its annual results, the net sales increased by 1 per cent to Rs 510 crore and net profit increased by 400 per cent to Rs 5 crore in FY23 compared to FY22.

The shares of the company have an ROE of 71 per cent and a ROCE of 103 per cent. The stock has delivered mind-boggling returns for investors, generating multibagger returns of 2,120 per cent in just 1 year, 6,150 per cent in 3 years, and a whopping 19,000 per cent in 5 years. Investors should keep an eye on this Small-Cap stock.

Disclaimer: The article is for informational purposes only and not investment advice.